These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15864111)

  • 41. Susceptibility genes for the side effect of antipsychotics on body weight and obesity.
    Chagnon YC
    Curr Drug Targets; 2006 Dec; 7(12):1681-95. PubMed ID: 17168843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. -759C÷T polymorphism of the HTR2C gene is not correlated with atypical antipsychotics-induced weight gain, among Romanian psychotic patients.
    Grădinaru RC; Andreescu NI; Nussbaum LA; Farcaş SS; Dumitraşcu V; Suciu L; Puiu M
    Rom J Morphol Embryol; 2016; 57(4):1343-1349. PubMed ID: 28174802
    [TBL] [Abstract][Full Text] [Related]  

  • 43. -759C>T Polymorphism of the HTR2C Gene is Associated with Second Generation Antipsychotic-Induced Weight Gain in Female Patients with Schizophrenia.
    Daray FM; Rodante D; Carosella LG; Silva ME; Martínez M; Fernández Busch MV; Faccone DF; Rothlin RP; Maffía PC
    Pharmacopsychiatry; 2017 Jan; 50(1):14-18. PubMed ID: 27414739
    [No Abstract]   [Full Text] [Related]  

  • 44. Weight gain in newly diagnosed first-episode psychosis patients and healthy comparisons: one-year analysis.
    Strassnig M; Miewald J; Keshavan M; Ganguli R
    Schizophr Res; 2007 Jul; 93(1-3):90-8. PubMed ID: 17478082
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between HTR2C and HTR2A polymorphisms and metabolic abnormalities in patients treated with olanzapine or clozapine.
    Gunes A; Melkersson KI; Scordo MG; Dahl ML
    J Clin Psychopharmacol; 2009 Feb; 29(1):65-8. PubMed ID: 19142110
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
    Thompson A; Lavedan C; Volpi S
    Psychiatry Res; 2010 Feb; 175(3):271-3. PubMed ID: 20045196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetics of antipsychotic-induced weight gain: update and current perspectives.
    Kao AC; Müller DJ
    Pharmacogenomics; 2013 Dec; 14(16):2067-83. PubMed ID: 24279860
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.
    Reynolds GP; Yao Z; Zhang X; Sun J; Zhang Z
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):143-51. PubMed ID: 15695058
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association study of olanzapine-induced weight gain and therapeutic response with SERT gene polymorphisms in female schizophrenic patients.
    Bozina N; Medved V; Kuzman MR; Sain I; Sertic J
    J Psychopharmacol; 2007 Sep; 21(7):728-34. PubMed ID: 17092963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum leptin and triglyceride levels in patients on treatment with atypical antipsychotics.
    Atmaca M; Kuloglu M; Tezcan E; Ustundag B
    J Clin Psychiatry; 2003 May; 64(5):598-604. PubMed ID: 12755665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Association of -2548G/A functional polymorphism in the promoter region of leptin gene with antipsychotic agent-induced weight gain].
    Zhang ZJ; Yao ZJ; Mou XD; Chen JF; Zhu RX; Liu W; Zhang XR; Sun J; Hou G
    Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(24):2119-23. PubMed ID: 14720418
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gene polymorphism influencing treatment response in psychotic patients in a naturalistic setting.
    Alenius M; Wadelius M; Dahl ML; Hartvig P; Lindström L; Hammarlund-Udenaes M
    J Psychiatr Res; 2008 Sep; 42(11):884-93. PubMed ID: 18086475
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain.
    Malhotra AK; Correll CU; Chowdhury NI; Müller DJ; Gregersen PK; Lee AT; Tiwari AK; Kane JM; Fleischhacker WW; Kahn RS; Ophoff RA; Meltzer HY; Lencz T; Kennedy JL
    Arch Gen Psychiatry; 2012 Sep; 69(9):904-12. PubMed ID: 22566560
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Functional consequences of two HTR2C polymorphisms associated with antipsychotic-induced weight gain.
    Hill MJ; Reynolds GP
    Pharmacogenomics; 2011 May; 12(5):727-34. PubMed ID: 21391883
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of 5-HT2C receptor polymorphisms in the pharmacogenetics of antipsychotic drug treatment.
    Reynolds GP; Templeman LA; Zhang ZJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1021-8. PubMed ID: 15953671
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cannabinoid type 1 receptor gene polymorphisms are not associated with olanzapine-induced weight gain.
    Park YM; Choi JE; Kang SG; Koo SH; Kim L; Geum D; Lee HJ
    Hum Psychopharmacol; 2011; 26(4-5):332-7. PubMed ID: 21695734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Methylenetetrahydrofolate reductase (MTHFR) 677C/T polymorphism is associated with antipsychotic-induced weight gain in first-episode schizophrenia.
    Srisawat U; Reynolds GP; Zhang ZJ; Zhang XR; Arranz B; San L; Dalton CF
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):485-90. PubMed ID: 24229535
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic correlates of olanzapine-induced weight gain in schizophrenia subjects from north India: role of metabolic pathway genes.
    Srivastava V; Deshpande SN; Nimgaonkar VL; Lerer B; Thelma B
    Pharmacogenomics; 2008 Aug; 9(8):1055-68. PubMed ID: 18681781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A new genetic locus for antipsychotic-induced weight gain: A genome-wide study of first-episode psychosis patients using amisulpride (from the OPTiMiSE cohort).
    Ter Hark SE; Jamain S; Schijven D; Lin BD; Bakker MK; Boland-Auge A; Deleuze JF; Troudet R; Malhotra AK; Gülöksüz S; Vinkers CH; Ebdrup BH; Kahn RS; Leboyer M; Luykx JJ
    J Psychopharmacol; 2020 May; 34(5):524-531. PubMed ID: 32126890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.